Product
Cytokine-induced memory-like natural killer cells
1 clinical trial
2 indications
Indication
MelanomaIndication
Metastatic MelanomaClinical trial
Phase I Study of Memory-Like Natural Killer Cells With Nivolumab and Relatlimab in Advanced or Metastatic Melanoma After Progression on Checkpoint InhibitorsStatus: Not yet recruiting, Estimated PCD: 2028-09-30